

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.93252969 |
| 2 | cytidine metabolic process (GO:0046087) | 5.21319083 |
| 3 | cytidine catabolic process (GO:0006216) | 5.21319083 |
| 4 | cytidine deamination (GO:0009972) | 5.21319083 |
| 5 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.73556371 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.47252887 |
| 7 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.85155795 |
| 8 | L-fucose catabolic process (GO:0042355) | 3.74936784 |
| 9 | fucose catabolic process (GO:0019317) | 3.74936784 |
| 10 | L-fucose metabolic process (GO:0042354) | 3.74936784 |
| 11 | metallo-sulfur cluster assembly (GO:0031163) | 3.68091027 |
| 12 | iron-sulfur cluster assembly (GO:0016226) | 3.68091027 |
| 13 | positive regulation of defense response to virus by host (GO:0002230) | 3.64941345 |
| 14 | piRNA metabolic process (GO:0034587) | 3.62921136 |
| 15 | cellular response to interleukin-15 (GO:0071350) | 3.60791242 |
| 16 | tryptophan metabolic process (GO:0006568) | 3.49830263 |
| 17 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.39045248 |
| 18 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.39045248 |
| 19 | platelet dense granule organization (GO:0060155) | 3.37679618 |
| 20 | indole-containing compound catabolic process (GO:0042436) | 3.36955338 |
| 21 | indolalkylamine catabolic process (GO:0046218) | 3.36955338 |
| 22 | tryptophan catabolic process (GO:0006569) | 3.36955338 |
| 23 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.35575124 |
| 24 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.29235790 |
| 25 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.18088430 |
| 26 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.12700145 |
| 27 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.11158160 |
| 28 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.09625885 |
| 29 | sleep (GO:0030431) | 3.07731457 |
| 30 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.06108667 |
| 31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.02175948 |
| 32 | negative regulation of cell killing (GO:0031342) | 3.02175948 |
| 33 | branched-chain amino acid catabolic process (GO:0009083) | 3.01417860 |
| 34 | L-methionine salvage (GO:0071267) | 3.00919972 |
| 35 | L-methionine biosynthetic process (GO:0071265) | 3.00919972 |
| 36 | amino acid salvage (GO:0043102) | 3.00919972 |
| 37 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.97095133 |
| 38 | positive regulation of antigen processing and presentation (GO:0002579) | 2.94705919 |
| 39 | regulation of defense response to virus by host (GO:0050691) | 2.93874200 |
| 40 | actin nucleation (GO:0045010) | 2.93544505 |
| 41 | adaptation of signaling pathway (GO:0023058) | 2.92047222 |
| 42 | sequestering of actin monomers (GO:0042989) | 2.91080054 |
| 43 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.89962596 |
| 44 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.87621121 |
| 45 | protein-cofactor linkage (GO:0018065) | 2.87325340 |
| 46 | negative regulation of T cell apoptotic process (GO:0070233) | 2.86496482 |
| 47 | indolalkylamine metabolic process (GO:0006586) | 2.84610005 |
| 48 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.83529118 |
| 49 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.83052079 |
| 50 | S-adenosylmethionine metabolic process (GO:0046500) | 2.81707285 |
| 51 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.81373203 |
| 52 | mannosylation (GO:0097502) | 2.79639567 |
| 53 | organelle membrane fusion (GO:0090174) | 2.78794140 |
| 54 | DNA methylation involved in gamete generation (GO:0043046) | 2.78281850 |
| 55 | proteasome assembly (GO:0043248) | 2.77109454 |
| 56 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.76439428 |
| 57 | adenosine metabolic process (GO:0046085) | 2.74677877 |
| 58 | kynurenine metabolic process (GO:0070189) | 2.72334451 |
| 59 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.69705119 |
| 60 | response to pheromone (GO:0019236) | 2.67152811 |
| 61 | positive regulation of prostaglandin secretion (GO:0032308) | 2.66753511 |
| 62 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.65740237 |
| 63 | regulation of B cell apoptotic process (GO:0002902) | 2.63625328 |
| 64 | autophagic vacuole fusion (GO:0000046) | 2.63586690 |
| 65 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.62084317 |
| 66 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.61161468 |
| 67 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.60402657 |
| 68 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.60378975 |
| 69 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.57777433 |
| 70 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.57652289 |
| 71 | aggressive behavior (GO:0002118) | 2.56720873 |
| 72 | protein complex biogenesis (GO:0070271) | 2.54532296 |
| 73 | response to interleukin-15 (GO:0070672) | 2.51272383 |
| 74 | regulation of memory T cell differentiation (GO:0043380) | 2.50497715 |
| 75 | negative regulation of telomere maintenance (GO:0032205) | 2.50180200 |
| 76 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.50130310 |
| 77 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.49735028 |
| 78 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.49658304 |
| 79 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.48185901 |
| 80 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.46561123 |
| 81 | response to gravity (GO:0009629) | 2.46495240 |
| 82 | regulation of thymocyte apoptotic process (GO:0070243) | 2.44918698 |
| 83 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.44146973 |
| 84 | negative regulation of B cell apoptotic process (GO:0002903) | 2.42082155 |
| 85 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.41986727 |
| 86 | protein maturation by protein folding (GO:0022417) | 2.41565026 |
| 87 | regulation of gamma-delta T cell activation (GO:0046643) | 2.41311899 |
| 88 | regulation of chronic inflammatory response (GO:0002676) | 2.40978950 |
| 89 | regulation of T-helper 1 type immune response (GO:0002825) | 2.39016213 |
| 90 | cellular ketone body metabolic process (GO:0046950) | 2.38835969 |
| 91 | negative T cell selection (GO:0043383) | 2.37708844 |
| 92 | regulation of antigen processing and presentation (GO:0002577) | 2.37385589 |
| 93 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.36621707 |
| 94 | protein deneddylation (GO:0000338) | 2.35579448 |
| 95 | respiratory chain complex IV assembly (GO:0008535) | 2.35476562 |
| 96 | ATP synthesis coupled proton transport (GO:0015986) | 2.33678833 |
| 97 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.33678833 |
| 98 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.30847792 |
| 99 | negative regulation of innate immune response (GO:0045824) | 2.30668576 |
| 100 | positive thymic T cell selection (GO:0045059) | 2.30322223 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.54656626 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.54170489 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.22401494 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.20392005 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.91073663 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.90447749 |
| 7 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.75778961 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.72095713 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.71252672 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.70634542 |
| 11 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.53533044 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.47287701 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.42725852 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.41769089 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.41274799 |
| 16 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.39500006 |
| 17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.34254118 |
| 18 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.33270063 |
| 19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.27657270 |
| 20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.10308000 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.04994287 |
| 22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.03131288 |
| 23 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.87852629 |
| 24 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78753490 |
| 25 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.78746864 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 1.74458236 |
| 27 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.74295136 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.72332190 |
| 29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.69109824 |
| 30 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.68492156 |
| 31 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.67382716 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66264350 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65322106 |
| 34 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.64659832 |
| 35 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.61347361 |
| 36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.61150764 |
| 37 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.59264655 |
| 38 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53846874 |
| 39 | GATA3_26560356_Chip-Seq_TH2_Human | 1.52770106 |
| 40 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.52559346 |
| 41 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.50095722 |
| 42 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.44112779 |
| 43 | AR_20517297_ChIP-Seq_VCAP_Human | 1.44031441 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43373438 |
| 45 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.41957560 |
| 46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.40137205 |
| 47 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.40029447 |
| 48 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.38711239 |
| 49 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.38515089 |
| 50 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.38367163 |
| 51 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.37364666 |
| 52 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.36813705 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33637342 |
| 54 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.32998748 |
| 55 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.29579910 |
| 56 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.28949651 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28740047 |
| 58 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.28679736 |
| 59 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.25972264 |
| 60 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.25972264 |
| 61 | NCOR_22424771_ChIP-Seq_293T_Human | 1.22058178 |
| 62 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.21852860 |
| 63 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19347552 |
| 64 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.19144966 |
| 65 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.18970019 |
| 66 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.16441978 |
| 67 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.14405623 |
| 68 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.13326954 |
| 69 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.12125813 |
| 70 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.11994953 |
| 71 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.09495921 |
| 72 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07058298 |
| 73 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.07013685 |
| 74 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.06789241 |
| 75 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05944162 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05807805 |
| 77 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.04240076 |
| 78 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01280034 |
| 79 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00989374 |
| 80 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.00356618 |
| 81 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.99061981 |
| 82 | ERA_21632823_ChIP-Seq_H3396_Human | 0.98238581 |
| 83 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.97418585 |
| 84 | MYB_26560356_Chip-Seq_TH1_Human | 0.97278302 |
| 85 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.97170147 |
| 86 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.96904780 |
| 87 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96801472 |
| 88 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96688517 |
| 89 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.94372449 |
| 90 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.92917509 |
| 91 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.92798396 |
| 92 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.92753536 |
| 93 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.92140104 |
| 94 | P300_27268052_Chip-Seq_Bcells_Human | 0.91635546 |
| 95 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.91627987 |
| 96 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.91182447 |
| 97 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.89439984 |
| 98 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88445674 |
| 99 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.87663253 |
| 100 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.86401097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.88049299 |
| 2 | MP0005671_abnormal_response_to | 3.90631655 |
| 3 | MP0003724_increased_susceptibility_to | 3.16895068 |
| 4 | MP0008877_abnormal_DNA_methylation | 2.98726218 |
| 5 | MP0003787_abnormal_imprinting | 2.91999146 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 2.55521606 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.37917080 |
| 8 | MP0005084_abnormal_gallbladder_morpholo | 2.33662471 |
| 9 | MP0006072_abnormal_retinal_apoptosis | 2.24783055 |
| 10 | MP0004147_increased_porphyrin_level | 2.20487093 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.20387807 |
| 12 | MP0009785_altered_susceptibility_to | 2.16460270 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 1.98126447 |
| 14 | MP0005000_abnormal_immune_tolerance | 1.96941251 |
| 15 | MP0002102_abnormal_ear_morphology | 1.84332068 |
| 16 | MP0003763_abnormal_thymus_physiology | 1.82977459 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 1.82426101 |
| 18 | MP0001984_abnormal_olfaction | 1.76622974 |
| 19 | MP0002723_abnormal_immune_serum | 1.69682478 |
| 20 | MP0005646_abnormal_pituitary_gland | 1.66150073 |
| 21 | MP0001800_abnormal_humoral_immune | 1.65458698 |
| 22 | MP0000685_abnormal_immune_system | 1.63558958 |
| 23 | MP0002876_abnormal_thyroid_physiology | 1.59956984 |
| 24 | MP0003045_fibrosis | 1.58337648 |
| 25 | MP0002420_abnormal_adaptive_immunity | 1.54137555 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.53375358 |
| 27 | MP0005025_abnormal_response_to | 1.52314950 |
| 28 | MP0001819_abnormal_immune_cell | 1.51789040 |
| 29 | MP0001790_abnormal_immune_system | 1.49968215 |
| 30 | MP0005387_immune_system_phenotype | 1.49968215 |
| 31 | MP0003252_abnormal_bile_duct | 1.49538160 |
| 32 | MP0010234_abnormal_vibrissa_follicle | 1.49159193 |
| 33 | MP0005377_hearing/vestibular/ear_phenot | 1.47221685 |
| 34 | MP0003878_abnormal_ear_physiology | 1.47221685 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.46061024 |
| 36 | MP0004043_abnormal_pH_regulation | 1.43921002 |
| 37 | MP0005645_abnormal_hypothalamus_physiol | 1.42587815 |
| 38 | MP0003195_calcinosis | 1.41521161 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.41282734 |
| 40 | MP0005253_abnormal_eye_physiology | 1.40459026 |
| 41 | MP0005551_abnormal_eye_electrophysiolog | 1.38112726 |
| 42 | MP0003011_delayed_dark_adaptation | 1.36589691 |
| 43 | MP0001501_abnormal_sleep_pattern | 1.35247144 |
| 44 | MP0003786_premature_aging | 1.34389203 |
| 45 | MP0005332_abnormal_amino_acid | 1.30831199 |
| 46 | MP0001905_abnormal_dopamine_level | 1.30166575 |
| 47 | MP0003866_abnormal_defecation | 1.29400643 |
| 48 | MP0001968_abnormal_touch/_nociception | 1.27384630 |
| 49 | MP0003646_muscle_fatigue | 1.26691920 |
| 50 | MP0008872_abnormal_physiological_respon | 1.24369743 |
| 51 | MP0002139_abnormal_hepatobiliary_system | 1.23225959 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.22648539 |
| 53 | MP0002419_abnormal_innate_immunity | 1.21107663 |
| 54 | MP0002837_dystrophic_cardiac_calcinosis | 1.18146450 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.18063475 |
| 56 | MP0003718_maternal_effect | 1.17898684 |
| 57 | MP0001764_abnormal_homeostasis | 1.17395300 |
| 58 | MP0000013_abnormal_adipose_tissue | 1.15055504 |
| 59 | MP0006082_CNS_inflammation | 1.14895489 |
| 60 | MP0009764_decreased_sensitivity_to | 1.10567233 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.10030238 |
| 62 | MP0002254_reproductive_system_inflammat | 1.09954618 |
| 63 | MP0002277_abnormal_respiratory_mucosa | 1.09223221 |
| 64 | MP0002163_abnormal_gland_morphology | 1.09119595 |
| 65 | MP0001756_abnormal_urination | 1.09107037 |
| 66 | MP0009046_muscle_twitch | 1.09004275 |
| 67 | MP0002166_altered_tumor_susceptibility | 1.06852388 |
| 68 | MP0002693_abnormal_pancreas_physiology | 1.00897113 |
| 69 | MP0000716_abnormal_immune_system | 1.00470540 |
| 70 | MP0005083_abnormal_biliary_tract | 0.97351534 |
| 71 | MP0002398_abnormal_bone_marrow | 0.96399173 |
| 72 | MP0006276_abnormal_autonomic_nervous | 0.94879442 |
| 73 | MP0005410_abnormal_fertilization | 0.93520447 |
| 74 | MP0005636_abnormal_mineral_homeostasis | 0.93394838 |
| 75 | MP0002722_abnormal_immune_system | 0.91757818 |
| 76 | MP0008469_abnormal_protein_level | 0.91408676 |
| 77 | MP0002405_respiratory_system_inflammati | 0.91193000 |
| 78 | MP0002006_tumorigenesis | 0.89862046 |
| 79 | MP0000538_abnormal_urinary_bladder | 0.89646553 |
| 80 | MP0001873_stomach_inflammation | 0.88391463 |
| 81 | MP0004142_abnormal_muscle_tone | 0.87710081 |
| 82 | MP0009643_abnormal_urine_homeostasis | 0.86954040 |
| 83 | MP0009745_abnormal_behavioral_response | 0.86308546 |
| 84 | MP0002736_abnormal_nociception_after | 0.86206197 |
| 85 | MP0005165_increased_susceptibility_to | 0.85829428 |
| 86 | MP0001661_extended_life_span | 0.85604879 |
| 87 | MP0006036_abnormal_mitochondrial_physio | 0.84005610 |
| 88 | MP0010155_abnormal_intestine_physiology | 0.83190345 |
| 89 | MP0003638_abnormal_response/metabolism_ | 0.81920953 |
| 90 | MP0008058_abnormal_DNA_repair | 0.79831179 |
| 91 | MP0001986_abnormal_taste_sensitivity | 0.79775292 |
| 92 | MP0005310_abnormal_salivary_gland | 0.78079432 |
| 93 | MP0003075_altered_response_to | 0.77775641 |
| 94 | MP0002877_abnormal_melanocyte_morpholog | 0.77448023 |
| 95 | MP0002429_abnormal_blood_cell | 0.77434116 |
| 96 | MP0004145_abnormal_muscle_electrophysio | 0.77017506 |
| 97 | MP0005379_endocrine/exocrine_gland_phen | 0.75087010 |
| 98 | MP0006035_abnormal_mitochondrial_morpho | 0.74286526 |
| 99 | MP0000465_gastrointestinal_hemorrhage | 0.73970627 |
| 100 | MP0010329_abnormal_lipoprotein_level | 0.73617436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Tongue fasciculations (HP:0001308) | 3.69012052 |
| 2 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.61274113 |
| 3 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.61274113 |
| 4 | Generalized aminoaciduria (HP:0002909) | 3.50551304 |
| 5 | Congenital stationary night blindness (HP:0007642) | 3.48030451 |
| 6 | Hepatic necrosis (HP:0002605) | 3.47305839 |
| 7 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.47129578 |
| 8 | Muscle fibrillation (HP:0010546) | 3.40548013 |
| 9 | IgG deficiency (HP:0004315) | 3.33367307 |
| 10 | Methylmalonic acidemia (HP:0002912) | 3.29705409 |
| 11 | Hepatocellular necrosis (HP:0001404) | 3.28383647 |
| 12 | Acute necrotizing encephalopathy (HP:0006965) | 3.27978177 |
| 13 | Mitochondrial inheritance (HP:0001427) | 3.26472884 |
| 14 | Severe combined immunodeficiency (HP:0004430) | 3.26432602 |
| 15 | Increased CSF lactate (HP:0002490) | 3.25565045 |
| 16 | Stomatitis (HP:0010280) | 3.20193502 |
| 17 | Abolished electroretinogram (ERG) (HP:0000550) | 3.19984120 |
| 18 | Methylmalonic aciduria (HP:0012120) | 2.96987918 |
| 19 | Hypothermia (HP:0002045) | 2.88695222 |
| 20 | Type I transferrin isoform profile (HP:0003642) | 2.84877211 |
| 21 | Progressive macrocephaly (HP:0004481) | 2.81823229 |
| 22 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.79313157 |
| 23 | T lymphocytopenia (HP:0005403) | 2.75885079 |
| 24 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.75141244 |
| 25 | Dicarboxylic aciduria (HP:0003215) | 2.75141244 |
| 26 | Thyroiditis (HP:0100646) | 2.74054696 |
| 27 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.73721824 |
| 28 | Prostate neoplasm (HP:0100787) | 2.71306582 |
| 29 | Abnormality of T cell number (HP:0011839) | 2.67319669 |
| 30 | Acute encephalopathy (HP:0006846) | 2.63557952 |
| 31 | Increased muscle lipid content (HP:0009058) | 2.61391089 |
| 32 | Increased intramyocellular lipid droplets (HP:0012240) | 2.59245387 |
| 33 | Abnormality of the prostate (HP:0008775) | 2.59156599 |
| 34 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.59108771 |
| 35 | Abnormal protein glycosylation (HP:0012346) | 2.59108771 |
| 36 | Abnormal glycosylation (HP:0012345) | 2.59108771 |
| 37 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.59108771 |
| 38 | Ketosis (HP:0001946) | 2.58407952 |
| 39 | Renal cortical cysts (HP:0000803) | 2.57758524 |
| 40 | Ketoacidosis (HP:0001993) | 2.55930352 |
| 41 | 3-Methylglutaconic aciduria (HP:0003535) | 2.55488313 |
| 42 | Lactic acidosis (HP:0003128) | 2.50901027 |
| 43 | Lipid accumulation in hepatocytes (HP:0006561) | 2.48186721 |
| 44 | Hypoalbuminemia (HP:0003073) | 2.46713809 |
| 45 | Abnormal albumin level (HP:0012116) | 2.46713809 |
| 46 | Delayed CNS myelination (HP:0002188) | 2.42024075 |
| 47 | Cerebral edema (HP:0002181) | 2.39130191 |
| 48 | Chronic diarrhea (HP:0002028) | 2.38890447 |
| 49 | Abnormality of vitamin B metabolism (HP:0004340) | 2.37738344 |
| 50 | Increased serum lactate (HP:0002151) | 2.37408786 |
| 51 | Combined immunodeficiency (HP:0005387) | 2.37153134 |
| 52 | Lethargy (HP:0001254) | 2.35539119 |
| 53 | Opisthotonus (HP:0002179) | 2.29383045 |
| 54 | Type II lissencephaly (HP:0007260) | 2.29378153 |
| 55 | Reduced antithrombin III activity (HP:0001976) | 2.28024132 |
| 56 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.23519619 |
| 57 | Abnormality of the renal cortex (HP:0011035) | 2.19582627 |
| 58 | Attenuation of retinal blood vessels (HP:0007843) | 2.16183176 |
| 59 | Abnormality of eosinophils (HP:0001879) | 2.14244419 |
| 60 | Agitation (HP:0000713) | 2.13649760 |
| 61 | Acute hepatic failure (HP:0006554) | 2.08133564 |
| 62 | Optic neuritis (HP:0100653) | 2.02289619 |
| 63 | Retrobulbar optic neuritis (HP:0100654) | 2.02289619 |
| 64 | Abnormality of T cells (HP:0002843) | 2.00396964 |
| 65 | Pancreatic cysts (HP:0001737) | 2.00266950 |
| 66 | Hypomagnesemia (HP:0002917) | 1.99785930 |
| 67 | Respiratory failure (HP:0002878) | 1.99180757 |
| 68 | Retinal dysplasia (HP:0007973) | 1.99121517 |
| 69 | Lissencephaly (HP:0001339) | 1.97247680 |
| 70 | Severe muscular hypotonia (HP:0006829) | 1.96538395 |
| 71 | Pancreatitis (HP:0001733) | 1.95704224 |
| 72 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.94531886 |
| 73 | Increased hepatocellular lipid droplets (HP:0006565) | 1.93305616 |
| 74 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.90966406 |
| 75 | Myositis (HP:0100614) | 1.89760455 |
| 76 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.88467514 |
| 77 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.88467514 |
| 78 | Abnormality of glycolipid metabolism (HP:0010969) | 1.88467514 |
| 79 | Oligomenorrhea (HP:0000876) | 1.87694530 |
| 80 | Medial flaring of the eyebrow (HP:0010747) | 1.87622784 |
| 81 | Optic disc pallor (HP:0000543) | 1.87451837 |
| 82 | Progressive microcephaly (HP:0000253) | 1.86452101 |
| 83 | Hypoproteinemia (HP:0003075) | 1.81721109 |
| 84 | Glycosuria (HP:0003076) | 1.81414272 |
| 85 | Abnormality of urine glucose concentration (HP:0011016) | 1.81414272 |
| 86 | Inability to walk (HP:0002540) | 1.80109477 |
| 87 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.79381230 |
| 88 | Facial diplegia (HP:0001349) | 1.79132425 |
| 89 | Pachygyria (HP:0001302) | 1.78418652 |
| 90 | Anorexia (HP:0002039) | 1.76514066 |
| 91 | Exercise intolerance (HP:0003546) | 1.75754596 |
| 92 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.75697549 |
| 93 | Abnormality of alanine metabolism (HP:0010916) | 1.75697549 |
| 94 | Hyperalaninemia (HP:0003348) | 1.75697549 |
| 95 | Progressive inability to walk (HP:0002505) | 1.74421369 |
| 96 | Renal Fanconi syndrome (HP:0001994) | 1.74352491 |
| 97 | Failure to thrive in infancy (HP:0001531) | 1.73449320 |
| 98 | Abnormality of magnesium homeostasis (HP:0004921) | 1.72879355 |
| 99 | Orchitis (HP:0100796) | 1.72517876 |
| 100 | Hemiparesis (HP:0001269) | 1.72142579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 5.86188080 |
| 2 | TAOK3 | 4.34235193 |
| 3 | BCKDK | 3.54269665 |
| 4 | MAP4K2 | 3.45891109 |
| 5 | TXK | 3.18503775 |
| 6 | KDR | 2.82514989 |
| 7 | GRK1 | 2.57270579 |
| 8 | LIMK1 | 2.20081789 |
| 9 | TESK1 | 2.20008153 |
| 10 | VRK2 | 2.17430700 |
| 11 | FRK | 2.06442826 |
| 12 | ZAK | 2.05823652 |
| 13 | MAP3K14 | 1.93448401 |
| 14 | EIF2AK3 | 1.87737322 |
| 15 | MST4 | 1.82282473 |
| 16 | ADRBK2 | 1.75940136 |
| 17 | MAP2K2 | 1.64327702 |
| 18 | GRK6 | 1.63425875 |
| 19 | TLK1 | 1.59110375 |
| 20 | MAPKAPK3 | 1.57430657 |
| 21 | FES | 1.45447107 |
| 22 | ITK | 1.43430556 |
| 23 | PHKG1 | 1.37287124 |
| 24 | PHKG2 | 1.37287124 |
| 25 | OXSR1 | 1.36736072 |
| 26 | NUAK1 | 1.33776533 |
| 27 | IKBKB | 1.29281852 |
| 28 | PINK1 | 1.25046194 |
| 29 | PRKCQ | 1.18255283 |
| 30 | BUB1 | 1.12695922 |
| 31 | BMPR1B | 1.04512313 |
| 32 | SIK3 | 1.04007777 |
| 33 | MAP4K1 | 1.02992631 |
| 34 | CSNK1G1 | 0.98604642 |
| 35 | CSNK1G3 | 0.98014736 |
| 36 | RPS6KA5 | 0.97395451 |
| 37 | MAP3K12 | 0.97020571 |
| 38 | MAPKAPK5 | 0.96513622 |
| 39 | TBK1 | 0.94240179 |
| 40 | DAPK1 | 0.93944222 |
| 41 | MAP3K11 | 0.90552741 |
| 42 | CDK19 | 0.88887859 |
| 43 | KIT | 0.87836597 |
| 44 | SYK | 0.87278629 |
| 45 | IKBKE | 0.83961026 |
| 46 | SCYL2 | 0.83864876 |
| 47 | MUSK | 0.83645112 |
| 48 | ARAF | 0.83425771 |
| 49 | WNK4 | 0.82711635 |
| 50 | BMPR2 | 0.77249683 |
| 51 | TEC | 0.75974385 |
| 52 | INSRR | 0.73733510 |
| 53 | SRPK1 | 0.69737534 |
| 54 | STK39 | 0.68907243 |
| 55 | PRKCI | 0.68459818 |
| 56 | SIK2 | 0.66718399 |
| 57 | MATK | 0.66263587 |
| 58 | DAPK2 | 0.66097287 |
| 59 | TNK2 | 0.65385617 |
| 60 | CSNK1G2 | 0.64820990 |
| 61 | TIE1 | 0.64586753 |
| 62 | CSNK1A1L | 0.63980370 |
| 63 | ERBB3 | 0.60380054 |
| 64 | VRK1 | 0.58776518 |
| 65 | BTK | 0.58002856 |
| 66 | LCK | 0.57099004 |
| 67 | TAOK2 | 0.55658913 |
| 68 | IRAK4 | 0.53441051 |
| 69 | PIM2 | 0.52785763 |
| 70 | LYN | 0.52539878 |
| 71 | FLT3 | 0.52240144 |
| 72 | JAK3 | 0.51674247 |
| 73 | FER | 0.50029967 |
| 74 | CSK | 0.48692017 |
| 75 | MAP2K7 | 0.46331419 |
| 76 | PAK6 | 0.45048761 |
| 77 | DYRK2 | 0.44672443 |
| 78 | TRIM28 | 0.44398426 |
| 79 | ADRBK1 | 0.43934756 |
| 80 | PRKCE | 0.41931641 |
| 81 | HCK | 0.41752081 |
| 82 | GRK7 | 0.41069344 |
| 83 | BCR | 0.40615322 |
| 84 | STK16 | 0.38558015 |
| 85 | MAP2K6 | 0.36780067 |
| 86 | PASK | 0.35282974 |
| 87 | MAP3K13 | 0.34691832 |
| 88 | PRKCG | 0.32876992 |
| 89 | PAK3 | 0.32562782 |
| 90 | CDK3 | 0.31938235 |
| 91 | CHUK | 0.31641089 |
| 92 | CCNB1 | 0.31216720 |
| 93 | CAMK2A | 0.30845151 |
| 94 | TSSK6 | 0.30721911 |
| 95 | MAPK11 | 0.29271547 |
| 96 | PRKCA | 0.28055724 |
| 97 | MYLK | 0.27534564 |
| 98 | TAOK1 | 0.27243651 |
| 99 | TAF1 | 0.27100972 |
| 100 | IGF1R | 0.26992512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.12194461 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 2.95738850 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.82397070 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.54526631 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.52007210 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.38994156 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.30149386 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.27833795 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.19956523 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.12394338 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.11255493 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.03593454 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.02832856 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.99862529 |
| 15 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.88073847 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.81369497 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.76827953 |
| 18 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.72137999 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.69568309 |
| 20 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.61815244 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.61614719 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.58266330 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.57169855 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.54427460 |
| 25 | RNA polymerase_Homo sapiens_hsa03020 | 1.52801928 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.44817110 |
| 27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.38706346 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.34767428 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.32428357 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.30250994 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.29734219 |
| 32 | Alzheimers disease_Homo sapiens_hsa05010 | 1.25839792 |
| 33 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.23346470 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.18466183 |
| 35 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.18053732 |
| 36 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.16259949 |
| 37 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.14893016 |
| 38 | Base excision repair_Homo sapiens_hsa03410 | 1.14017544 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.14003315 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12938859 |
| 41 | Purine metabolism_Homo sapiens_hsa00230 | 1.11812419 |
| 42 | Homologous recombination_Homo sapiens_hsa03440 | 1.11207254 |
| 43 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.05504421 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.05071532 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.03647734 |
| 46 | Huntingtons disease_Homo sapiens_hsa05016 | 1.03005277 |
| 47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.95526573 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.90306611 |
| 49 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.88931347 |
| 50 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.87560303 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 0.83181759 |
| 52 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82980296 |
| 53 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.81678301 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.81269161 |
| 55 | Retinol metabolism_Homo sapiens_hsa00830 | 0.81210202 |
| 56 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.80709182 |
| 57 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.73605989 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73268030 |
| 59 | Basal transcription factors_Homo sapiens_hsa03022 | 0.71352611 |
| 60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.71091109 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 0.69307828 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68232304 |
| 63 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.68177619 |
| 64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.67839233 |
| 65 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67088224 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.67053643 |
| 67 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.65145281 |
| 68 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64344696 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63974496 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63164039 |
| 71 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.62909857 |
| 72 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.61554416 |
| 73 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.59799816 |
| 74 | Shigellosis_Homo sapiens_hsa05131 | 0.59032660 |
| 75 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.57750231 |
| 76 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.57098224 |
| 77 | Leishmaniasis_Homo sapiens_hsa05140 | 0.56717214 |
| 78 | Salivary secretion_Homo sapiens_hsa04970 | 0.56578999 |
| 79 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56337095 |
| 80 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56285701 |
| 81 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.50731193 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49342692 |
| 83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.49196968 |
| 84 | Mismatch repair_Homo sapiens_hsa03430 | 0.47241305 |
| 85 | Olfactory transduction_Homo sapiens_hsa04740 | 0.45289039 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44811716 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44746843 |
| 88 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.44459727 |
| 89 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40468140 |
| 90 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.40108276 |
| 91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.39885878 |
| 92 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.39226114 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.38803668 |
| 94 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.38316396 |
| 95 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36419939 |
| 96 | Lysosome_Homo sapiens_hsa04142 | 0.35924191 |
| 97 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.34571069 |
| 98 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34327545 |
| 99 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.34256744 |
| 100 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.33908764 |

